Clinical Trial Update: Butyrate Adjuvant Therapy for Type 1 Diabetes [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating butyrate as adjuvant therapy for type 1 diabetes has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Butyrate Adjuvant Therapy (butyrate (butyric acid))

Snippet

Sponsor: Mayo Clinic | Conditions: Type1diabetes | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-03-31